Silence Therapeutics - 5 Year Stock Price History | SLN

Historical daily share price chart and data for Silence Therapeutics since 2020 adjusted for splits and dividends. The latest closing stock price for Silence Therapeutics as of June 09, 2025 is 5.31.
  • The all-time high Silence Therapeutics stock closing price was 28.35 on June 28, 2021.
  • The Silence Therapeutics 52-week high stock price is 22.46, which is 323% above the current share price.
  • The Silence Therapeutics 52-week low stock price is 1.97, which is 62.9% below the current share price.
  • The average Silence Therapeutics stock price for the last 52 weeks is 11.01.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Silence Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 4.4508 7.1900 7.4100 2.1800 5.3100 -22.82%
2024 18.5799 18.5500 26.2500 6.3300 6.8800 -60.39%
2023 9.1092 14.6900 17.6700 4.6100 17.3700 13.90%
2022 13.9111 23.8900 23.8900 7.9900 15.2500 -36.17%
2021 24.2000 24.0000 28.3500 20.6100 23.8900 8.59%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $0.043B
Silence Therapeutics plc focuses on the discovery, development and delivery of novel RNA therapeutics in hematology, cardiovascular and other rare and metabolic indications. The Company's product candidate consist SLN124 for the treatment of iron overload disorders; SLN360 for the cardiovascular disease with high lipoprotein and SLN500 for the treatment of complement-mediated diseases which are in clinical stage. Silence Therapeutics plc is based in London, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.949B 32.62
Zoetis (ZTS) United States $75.757B 28.27
Takeda Pharmaceutical (TAK) Japan $47.602B 9.47
Daiichi Sankyo, - (DSNKY) Japan $45.824B 23.49
BeOne Medicines - (ONC) Cayman Islands $28.015B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.544B 0.00
Merck (MKKGY) Germany $16.989B 12.45
Summit Therapeutics (SMMT) United States $15.291B 0.00
United Therapeutics (UTHR) United States $14.697B 13.00
Shionogi (SGIOY) Japan $14.292B 0.00
Neurocrine Biosciences (NBIX) United States $12.409B 42.51
IPSEN (IPSEY) France $10.165B 0.00
Orion OYJ (ORINY) Finland $10.083B 27.27
Corcept Therapeutics (CORT) United States $7.381B 60.00
Stevanato Group S.p.A (STVN) Italy $7.189B 43.96
Madrigal Pharmaceuticals (MDGL) United States $6.178B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.064B 0.00
Ionis Pharmaceuticals (IONS) United States $5.617B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.913B 14.94
Soleno Therapeutics (SLNO) United States $3.805B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.156B 11.06
Crinetics Pharmaceuticals (CRNX) United States $3.091B 0.00
Hypermarcas (HYPMY) Brazil $2.958B 19.46
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.388B 12.91
BioCryst Pharmaceuticals (BCRX) United States $2.310B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.261B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.232B 0.00
Indivior (INDV) United States $1.940B 8.23
Dyne Therapeutics (DYN) United States $1.671B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.592B 0.00
Evotec AG (EVO) Germany $1.438B 0.00
Ocular Therapeutix (OCUL) United States $1.437B 0.00
ARS Pharmaceuticals (SPRY) United States $1.423B 0.00
Guardian Pharmacy Services (GRDN) United States $1.307B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.107B 22.14
Harrow (HROW) United States $1.086B 0.00
Akebia Therapeutics (AKBA) United States $1.043B 0.00
Enliven Therapeutics (ELVN) United States $1.018B 0.00
Collegium Pharmaceutical (COLL) United States $0.970B 5.23
Avadel Pharmaceuticals (AVDL) Ireland $0.940B 0.00
Ardelyx (ARDX) United States $0.880B 0.00
Cronos Group (CRON) Canada $0.764B 0.00
Xeris Biopharma Holdings (XERS) United States $0.716B 0.00
KalVista Pharmaceuticals (KALV) United States $0.714B 0.00
Xencor (XNCR) United States $0.687B 0.00
Liminatus Pharma (LIMN) United States $0.630B 0.00
Elite Pharmaceuticals (ELTP) United States $0.620B 0.00
AleAnna (ANNA) United States $0.617B 0.00
Relay Therapeutics (RLAY) United States $0.576B 0.00
Regulus Therapeutics (RGLS) United States $0.569B 0.00
Theravance Biopharma (TBPH) United States $0.563B 0.00
Verve Therapeutics (VERV) United States $0.552B 0.00
Bioventus (BVS) United States $0.550B 13.94
USANA Health Sciences (USNA) United States $0.547B 11.90
Zevra Therapeutics (ZVRA) United States $0.506B 0.00
Tourmaline Bio (TRML) United States $0.495B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.475B 0.00
Oruka Therapeutics (ORKA) United States $0.471B 0.00
Altimmune (ALT) United States $0.456B 0.00
Siga Technologies (SIGA) United States $0.431B 9.00
Savara (SVRA) United States $0.422B 0.00
Organogenesis (ORGO) United States $0.384B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.384B 10.38
Aquestive Therapeutics (AQST) United States $0.354B 0.00
Heron Therapeutics (HRTX) United States $0.320B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.298B 0.00
ProKidney (PROK) United States $0.286B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 24.59
Esperion Therapeutics (ESPR) United States $0.242B 0.00
MediWound (MDWD) Israel $0.233B 0.00
Nanobiotix S.A (NBTX) France $0.222B 0.00
4D Molecular Therapeutics (FDMT) United States $0.202B 0.00
Lyell Immunopharma (LYEL) United States $0.189B 0.00
OmniAb (OABI) United States $0.183B 0.00
Journey Medical (DERM) United States $0.172B 0.00
Larimar Therapeutics (LRMR) United States $0.172B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Avita Medical (RCEL) United States $0.162B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.160B 0.00
Aldeyra Therapeutics (ALDX) United States $0.159B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Korro Bio (KRRO) United States $0.137B 0.00
Achieve Life Sciences (ACHV) Canada $0.133B 0.00
Lexeo Therapeutics (LXEO) United States $0.129B 0.00
Protara Therapeutics (TARA) United States $0.129B 0.00
Nektar Therapeutics (NKTR) United States $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Wellgistics Health (WGRX) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.106B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.098B 0.00
Fractyl Health (GUTS) United States $0.097B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.095B 15.66
VAXART, INC (VXRT) United States $0.093B 0.00
Inotiv (NOTV) United States $0.092B 0.00
Unicycive Therapeutics (UNCY) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 64.67
Nutriband (NTRB) United States $0.086B 0.00
Pyxis Oncology (PYXS) United States $0.084B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Dominari Holdings (DOMH) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Metagenomi (MGX) United States $0.065B 0.00
Telomir Pharmaceuticals (TELO) United States $0.064B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
Century Therapeutics (IPSC) United States $0.053B 0.00
PMV Pharmaceuticals (PMVP) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Avalo Therapeutics (AVTX) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.036B 0.00
PolyPid (PYPD) Israel $0.033B 0.00
China SXT Pharmaceuticals (SXTC) China $0.033B 0.00
Lyra Therapeutics (LYRA) United States $0.032B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Tempest Therapeutics (TPST) United States $0.030B 0.00
Relmada Therapeutics (RLMD) United States $0.028B 0.00
Jupiter Neurosciences (JUNS) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Mannatech (MTEX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Lipocine (LPCN) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.24
GlycoMimetics (GLYC) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
SHINECO (SISI) China $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00